IFNA1 and systemic sclerosis: Exogenous delivery of miRNA-26a-2-3p to TLR-stimulated monocyte can inhibit some IFN-stimulated genes, such as IRF6, GBP2, IFI44L, Siglec1, and IFN-β, thereby blocking IFN signal transduction in SSc development.